Real-time enrollment status for this advanced or metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:58 PM UTC
| NCT Number | NCT06724016 |
| Recruiting Status | Recruiting |
| Condition | Advanced or Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 292 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Last Updated on CT.gov | December 17, 2025 (Dec 17, 2025) |
As of August 28, 2026: Clinical trial NCT06724016 is currently recruiting participants. This phase1 study for advanced or metastatic solid tumors is actively seeking new participants at 2 locations across the United States. The study is sponsored by Hanmi Pharmaceutical Company Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06724016 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06724016 was last updated Dec 17, 2025 (December 17, 2025). HelloStudys verifies this status automatically.